Skip to main navigation Skip to search Skip to main content

Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial

Karen E. Anderson, David Stamler, Mat D. Davis, Stewart A. Factor, Robert A. Hauser, Jouko Isojärvi, L. Fredrik Jarskog, Joohi Jimenez-Shahed, Rajeev Kumar, Joseph P. McEvoy, Stanislaw Ochudlo, William G. Ondo, Hubert H. Fernandez

Research output: Contribution to journal › Article › peer-review

178   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science